Basivertebral Nerve Ablation: Five-Year Results Show Durable Relief and a Strong Safety Record

Basivertebral Nerve Ablation: Five-Year Results Show Durable Relief and a Strong Safety Record

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published June 17, 2025 | Category: Pain Medicine

Basivertebral nerve ablation (BVNA) treats chronic low back pain that comes from damaged vertebral endplates, a condition called vertebrogenic pain, which shows up on MRI as Modic changes. A probe placed inside the vertebral body heats the nerve that carries these pain signals. A 2024 analysis in Interventional Pain Medicine pooled 5-year results from three prospective trials.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors combined long-term follow-up from three trials of BVNA: the treatment arms of two randomized controlled trials (one versus sham, one versus standard care) and a single-arm study. Of 320 treated participants, 249 (78%) completed a 5-year visit, at an average of 5.6 years.

What they found

  • Pain scores improved by an average of 4.3 points (from 6.8 at baseline), and disability scores improved substantially.
  • About one-third of patients reported no pain at all at 5 years.
  • Among patients taking opioids at baseline, 65% were no longer taking them, and spinal injections fell by 58%.
  • 13% had further treatment at the same level, including 6% who had lumbar fusion.
  • There were no serious device- or procedure-related adverse events during long-term follow-up.

Why this matters

Long-term safety data are essential for any procedure that enters the bone. These results support BVNA as a durable and safe option for carefully selected patients with vertebrogenic pain confirmed on MRI.

Limitations

The long-term follow-up was open-label without a control group, and about one in five participants did not complete the 5-year visit. Some trials were industry-sponsored.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Select patients carefully, with typical symptoms and Modic changes on MRI.
  • Use careful image-guided access to the vertebral body, and review imaging for anatomical risks.
  • Track long-term outcomes and adverse events in your own patients.

For hospitals, clinics and safety leaders

  • Include newer procedures in outcome and complication monitoring programs.

For patients and families

  • Ask whether your MRI shows the specific findings this procedure is designed to treat.

Reference

  1. Khalil JG, Truumees E, Macadaeg K, Nguyen DTD, Moore GA, Lukes D, et al. Intraosseous basivertebral nerve ablation: A 5-year pooled analysis from three prospective clinical trials. Interv Pain Med. 2024 Dec;3(4):100529. doi:10.1016/j.inpm.2024.100529. PMID: 39758714. PubMed: https://pubmed.ncbi.nlm.nih.gov/39758714/

This article is educational information, not legal or medical advice.

Previous
Previous

Preprocedure MRI Changed Spinal Cord Stimulator Trial Plans for 7% of Patients

Next
Next

Small Doses of Contrast Dye During Epidural Injections Did Not Cause Thyroid Problems